Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 12.3B | 14.2B | 14.3B | 14.0B |
Cost of revenue | 11.1B | 12.3B | 12.4B | 12.4B |
Gross profit | 1.2B | 1.9B | 1.9B | 1.6B |
Operating expense | ||||
Research & development | 311.8M | 348.2M | 326.0M | 327.7M |
Selling general and admin | 1.0B | -1.1B | 2.1B | -50.9M |
Other operating expenses | 31.8M | 51.9M | 28.9M | 44.1M |
Operating income | -158.8M | 505.7M | 514.9M | 230.4M |
Non operating interest income | ||||
Income | 33.7M | 30.7M | 30.4M | 39.5M |
Expense | 110.7M | 115.7M | 151.6M | 115.1M |
Other income expense | — | — | — | — |
Pretax income | -275.8M | 253.3M | 157.8M | 170.4M |
Tax provision | 22.7M | 186.9M | 70.5M | 39.9M |
Net income | -298.5M | 66.4M | 87.2M | 130.5M |
Basic EPS | 0.0 | — | — | — |
Diluted EPS | 0.0 | — | — | — |
Basic average shares | 4.5B | — | — | — |
Diluted average shares | 4.5B | — | — | — |
EBITDA | -124.3M | 436.7M | 529.0M | 266.5M |
Net income from continuing op. | — | — | — | — |
Minority interests | 128.6M | -52.9M | -60.7M | -82.5M |
Preferred stock dividends | 0 | 0 | 0 | 0 |